Page 35 - Read Online
P. 35

Khokhar et al. Mini-invasive Surg 2022;6:2  https://dx.doi.org/10.20517/2574-1225.2021.97  Page 17 of 19

                    results from the multicenter international BASILICA registry. JACC Cardiovasc Interv 2021;14:941-8.  DOI  PubMed  PMC
               79.       Westermann D, Ludwig S, Kalbacher D, et al. Prevention of coronary obstruction in patients at risk undergoing transcatheter aortic
                    valve implantation: the Hamburg BASILICA experience. Clin Res Cardiol 2021;110:1900-11.  DOI  PubMed  PMC
               80.       Kitamura M, Majunke N, Holzhey D, et al. Systematic use of intentional leaflet laceration to prevent TAVI-induced coronary
                    obstruction: feasibility and early clinical outcomes of the BASILICA technique. EuroIntervention 2020;16:682-90.  DOI  PubMed
               81.       Makkar RR, Thourani VH, Mack MJ, et al; PARTNER 2 Investigators. Five-year outcomes of transcatheter or surgical aortic-valve
                    replacement. N Engl J Med 2020;382:799-809.  DOI  PubMed
               82.       Van Belle E, Vincent F, Labreuche J, et al. Balloon-expandable versus self-expanding transcatheter aortic valve replacement: a
                    propensity-matched comparison from the FRANCE-TAVI registry. Circulation 2020;141:243-59.  DOI  PubMed
               83.       Généreux P, Head SJ, Hahn R, et al. Paravalvular leak after transcatheter aortic valve replacement: the new Achilles’ heel? J Am Coll
                    Cardiol 2013;61:1125-36.  DOI  PubMed
               84.       Modolo R, Chang CC, Abdelghani M, et al. Quantitative assessment of acute regurgitation following TAVR: a multicenter pooled
                    analysis of 2,258 valves. JACC Cardiovasc Interv 2020;13:1303-11.  DOI  PubMed
               85.       Zoghbi WA, Asch FM, Bruce C, et al. Guidelines for the evaluation of valvular regurgitation after percutaneous valve repair or
                    replacement: a report from the American Society of Echocardiography Developed in Collaboration with the Society for
                    Cardiovascular Angiography and Interventions, Japanese Society of Echocardiography, and Society for Cardiovascular Magnetic
                    Resonance. J Am Soc Echocardiogr 2019;32:431-75.  DOI  PubMed
               86.       Akodad M, Lefèvre T. TAVI: simplification is the ultimate sophistication. Front Cardiovasc Med 2018;5:96.  DOI  PubMed  PMC
               87.       Abdelghani M, Soliman OI, Schultz C, Vahanian A, Serruys PW. Adjudicating paravalvular leaks of transcatheter aortic valves: a
                    critical appraisal. Eur Heart J 2016;37:2627-44.  DOI  PubMed
               88.       Sinning JM, Hammerstingl C, Vasa-Nicotera M, et al. Aortic regurgitation index defines severity of peri-prosthetic regurgitation and
                    predicts outcome in patients after transcatheter aortic valve implantation. J Am Coll Cardiol 2012;59:1134-41.  DOI  PubMed
               89.       Chahine J, Kadri AN, Gajulapalli RD, et al. Outcomes of transcatheter aortic valve replacement in mixed aortic valve disease. JACC
                    Cardiovasc Interv 2019;12:2299-306.  DOI  PubMed
               90.       Bagur R, Webb JG, Nietlispach F, et al. Acute kidney injury following transcatheter aortic valve implantation: predictive factors,
                    prognostic value, and comparison with surgical aortic valve replacement. Eur Heart J 2010;31:865-74.  DOI  PubMed  PMC
               91.       Takagi H, Niwa M, Mizuno Y, Goto SN, Umemoto T; All-Literature Investigation of Cardiovascular Evidence Group. Incidence,
                    predictors, and prognosis of acute kidney injury after transcatheter aortic valve implantation: a summary of contemporary studies
                    using Valve Academic Research Consortium definitions. Int J Cardiol 2013;168:1631-5.  DOI  PubMed
               92.       Julien HM, Stebbins A, Vemulapalli S, et al. Incidence, predictors, and outcomes of acute kidney injury in patients undergoing
                    transcatheter aortic valve replacement: insights from the Society of Thoracic Surgeons/American College of Cardiology National
                    Cardiovascular Data Registry-Transcatheter Valve Therapy Registry. Circ Cardiovasc Interv 2021;14:e010032.  DOI  PubMed
               93.       Nuis RJ, Van Mieghem NM, Tzikas A, et al. Frequency, determinants, and prognostic effects of acute kidney injury and red blood
                    cell transfusion in patients undergoing transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2011;77:881-9.  DOI
                    PubMed
               94.       Elhmidi Y, Bleiziffer S, Piazza N, et al. Incidence and predictors of acute kidney injury in patients undergoing transcatheter aortic
                    valve implantation. Am Heart J 2011;161:735-9.  DOI  PubMed
               95.       Kong WY, Yong G, Irish A. Incidence, risk factors and prognosis of acute kidney injury after transcatheter aortic valve implantation.
                    Nephrology (Carlton) 2012;17:445-51.  DOI  PubMed
               96.       Chandrasekhar J, Sartori S, Mehran R, et al. Incidence, predictors, and outcomes associated with acute kidney injury in patients
                    undergoing transcatheter aortic valve replacement: from the BRAVO-3 randomized trial. Clin Res Cardiol 2021;110:649-57.  DOI
                    PubMed
               97.       Yamamoto M, Hayashida K, Mouillet G, et al. Renal function-based contrast dosing predicts acute kidney injury following
                    transcatheter aortic valve implantation. JACC Cardiovasc Interv 2013;6:479-86.  DOI  PubMed
               98.       Giannini F, Latib A, Jabbour RJ, et al. The ratio of contrast volume to glomerular filtration rate predicts acute kidney injury and
                    mortality after transcatheter aortic valve implantation. Cardiovasc Revasc Med 2017;18:349-55.  DOI  PubMed
               99.       Barbanti M, Gulino S, Capranzano P, et al. Acute kidney injury with the RenalGuard system in patients undergoing transcatheter
                    aortic valve replacement: the PROTECT-TAVI trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic
                    intravenous hydraTion in Transcatheter Aortic Valve Implantation). JACC Cardiovasc Interv 2015;8:1595-604.  DOI  PubMed
               100.      Wang Y, Guo Y. RenalGuard system and conventional hydration for preventing contrast-associated acute kidney injury in patients
                    undergoing cardiac interventional procedures: a systematic review and meta-analysis. Int J Cardiol 2021;333:83-9.  DOI  PubMed
               101.      Suchá D, Kino A, Bogart K, et al. Effect of low contrast medium-dose CTA on device sizing and access vessel assessment for TAVR.
                    Eur J Radiol 2020;124:108826.  DOI  PubMed
               102.      Pulerwitz TC, Khalique OK, Nazif TN, et al. Very low intravenous contrast volume protocol for computed tomography angiography
                    providing comprehensive cardiac and vascular assessment prior to transcatheter aortic valve replacement in patients with chronic
                    kidney disease. J Cardiovasc Comput Tomogr 2016;10:316-21.  DOI  PubMed  PMC
               103.      Cavallo AU, Patterson AJ, Thomas R, et al. Low dose contrast CT for transcatheter aortic valve replacement assessment: results from
                    the prospective SPECTACULAR study (spectral CT assessment prior to TAVR). J Cardiovasc Comput Tomogr 2020;14:68-74.  DOI
                    PubMed
               104.      Higuchi R, Tobaru T, Hagiya K, et al. Renoprotective transcatheter aortic valve implantation without contrast media. Int Heart J
                    2018;59:1469-72.  DOI  PubMed
   30   31   32   33   34   35   36   37   38   39   40